Notice: Prescription Drug List (PDL): Hyoscine butylbromide (English, HTML)

View metadata and access the original English HTML file: Notice: Prescription Drug List (PDL): Hyoscine butylbromide.

Format

HTML

Access

file-only

Publisher-reported update

2023-09-30

The purpose of this Notice of Amendment is to notify that Health Canada will switch injectable Hyoscine butylbromide to prescription status from ethical status for human use by adding it to the Human Prescription Drug List (PDL). Injectable Hyoscine butylbromide is already listed on the Veterinary Prescription Drug List.

Access original file